ANALYTICAL CONTROL PROCEDURES OF IMMUNOREACTIVITY FOR IGG AND FAB FRAGMENTS SPECIFIC TO HAPTENS

被引:7
作者
CANO, NJ [1 ]
SABOURAUD, AE [1 ]
URTIZBEREA, M [1 ]
CARCAGNE, J [1 ]
GRANDGEORGE, M [1 ]
SCHERRMANN, JMG [1 ]
机构
[1] PASTEUR MERIEUX,MARCY LETOILE,FRANCE
关键词
IMMUNOREACTIVITY; IGG AND FAB FRAGMENTS; COLCHICINE; DIGOXIN; DIGITOXIN;
D O I
10.1023/A:1015802110647
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This study investigates immunoreactivity control procedures, i.e., specificity, affinity constant (K(a)), and specific active binding sites (SABS), for polyclonal anticolchicine, monoclonal antidigitoxin IgG and Fab fragments, and antidigoxin Fab fragments (Digidot). Preliminary control procedures for IgG and Fab fragment purity indicated that all reagents were immunologically pure. All IgG and Fab fragments exhibited similar cross-reactivity and K(a). No decrease in percentage of Fab fragment SABS was observed after papain cleavage of anticolchicine and antidigitoxin IgG. Nevertheless, only 4.3 +/- 1.2% of nonimmunopurified anticolchicine polyclonal Fab fragments and 76.2 +/- 2.3 to 88.7 +/- 2.5% of different batches of immunopurified anti-digoxin Fab (Digidot) were active, the latter percentage being in the range of the 85% specified by the manufacturer. Only 58 +/- 3% of digitoxin-specific monoclonal IgG was active and 67 +/- 7% of its Fab fragments. Results show the importance of determining the ratio of SABS to presumed total specific binding sites for pharmaceutical monoclonal and polyclonal antibody preparations against haptens.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 22 条
[1]   LARGE-SCALE PRODUCTION AND PURIFICATION OF PARAQUAT AND DESIPRAMINE MONOCLONAL-ANTIBODIES AND THEIR FAB FRAGMENTS [J].
BOWLES, M ;
JOHNSTON, SC ;
SCHOOF, DD ;
PENTEL, PR ;
POND, SM .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1988, 10 (05) :537-+
[2]   PREPARATION AND PROPERTIES OF SERUM AND PLASMA PROTEINS .4. A SYSTEM FOR THE SEPARATION INTO FRACTIONS OF THE PROTEIN AND LIPOPROTEIN COMPONENTS OF BIOLOGICAL TISSUES AND FLUIDS [J].
COHN, EJ ;
STRONG, LE ;
HUGHES, WL ;
MULFORD, DJ ;
ASHWORTH, JN ;
MELIN, M ;
TAYLOR, HL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (03) :459-475
[3]  
COLBURN WA, 1988, J CLIN IMMUNOASSAY, V11, P37
[4]   SPECIFIC BINDING CHARACTERISTICS OF HIGH-AFFINITY MONOCLONAL ANTIDIGITOXIN ANTIBODIES [J].
COLLIGNON, A ;
GENITEAULEGENDRE, M ;
SANDRE, C ;
QUERO, AM ;
LABARRE, C .
HYBRIDOMA, 1988, 7 (04) :355-366
[5]  
EDELMAN L, 1982, CR HEBD ACAD SCI, V3, P421
[6]   DIGOXIN IMMUNE FAB THERAPY IN THE MANAGEMENT OF DIGITALIS INTOXICATION - SAFETY AND EFFICACY RESULTS OF AN OBSERVATIONAL SURVEILLANCE STUDY [J].
HICKEY, AR ;
WENGER, TL ;
CARPENTER, VP ;
TILSON, HH ;
HLATKY, MA ;
FURBERG, CD ;
KIRKPATRICK, CH ;
STRAUSS, HC ;
SMITH, TW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (03) :590-598
[7]  
HURSTING MJ, 1987, CLIN CHEM, V33, P1652
[8]   PROTEIN ENGINEERING OF ANTIBODY-BINDING SITES - RECOVERY OF SPECIFIC ACTIVITY IN AN ANTI-DIGOXIN SINGLE-CHAIN FV ANALOG PRODUCED IN ESCHERICHIA-COLI [J].
HUSTON, JS ;
LEVINSON, D ;
MUDGETTHUNTER, M ;
TAI, MS ;
NOVOTNY, J ;
MARGOLIES, MN ;
RIDGE, RJ ;
BRUCCOLERI, RE ;
HABER, E ;
CREA, R ;
OPPERMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :5879-5883
[9]   ANALYTICAL APPROACHES TO THE STUDY OF MONOCLONAL-ANTIBODY STABILITY [J].
JISKOOT, W ;
BEUVERY, EC ;
DEKONING, AAM ;
HERRON, JN ;
CROMMELIN, DJA .
PHARMACEUTICAL RESEARCH, 1990, 7 (12) :1234-1241
[10]   THE WOOLF PLOT IS MORE RELIABLE THAN THE SCATCHARD PLOT IN ANALYZING DATA FROM HORMONE RECEPTOR ASSAYS [J].
KEIGHTLEY, DD ;
CRESSIE, NAC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1980, 13 (11) :1317-1323